177 related articles for article (PubMed ID: 21487651)
1. Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission.
Ago Y; Araki R; Yano K; Hiramatsu N; Kawasaki T; Chaki S; Nakazato A; Onoe H; Hashimoto H; Baba A; Takuma K; Matsuda T
Psychopharmacology (Berl); 2011 Oct; 217(3):443-52. PubMed ID: 21487651
[TBL] [Abstract][Full Text] [Related]
2. Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion.
Pehrson AL; Moghaddam B
Psychopharmacology (Berl); 2010 Sep; 211(4):443-55. PubMed ID: 20585759
[TBL] [Abstract][Full Text] [Related]
3. The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex.
Swanson CJ; Perry KW; Schoepp DD
J Neurochem; 2004 Jan; 88(1):194-202. PubMed ID: 14675163
[TBL] [Abstract][Full Text] [Related]
4. Role of Prefrontal Serotonergic and Dopaminergic Systems in Encounter-Induced Hyperactivity in Methamphetamine-Sensitized Mice.
Tanaka T; Ago Y; Umehara C; Imoto E; Hasebe S; Hashimoto H; Takuma K; Matsuda T
Int J Neuropsychopharmacol; 2017 May; 20(5):410-421. PubMed ID: 28034961
[TBL] [Abstract][Full Text] [Related]
5. Group III metabotropic glutamate receptor agonists selectively suppress excitatory synaptic currents in the rat prefrontal cortex induced by 5-hydroxytryptamine2A receptor activation.
Zhang C; Marek GJ
J Pharmacol Exp Ther; 2007 Jan; 320(1):437-47. PubMed ID: 17021259
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders.
Rorick-Kehn LM; Johnson BG; Knitowski KM; Salhoff CR; Witkin JM; Perry KW; Griffey KI; Tizzano JP; Monn JA; McKinzie DL; Schoepp DD
Psychopharmacology (Berl); 2007 Jul; 193(1):121-36. PubMed ID: 17384937
[TBL] [Abstract][Full Text] [Related]
7. The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses isolation rearing-induced abnormal behaviors in mice.
Ago Y; Araki R; Yano K; Kawasaki T; Chaki S; Nakazato A; Onoe H; Hashimoto H; Baba A; Takuma K; Matsuda T
J Pharmacol Sci; 2012; 118(2):295-8. PubMed ID: 22293290
[TBL] [Abstract][Full Text] [Related]
8. Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity.
Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
Synapse; 2009 Jan; 63(1):7-14. PubMed ID: 18925659
[TBL] [Abstract][Full Text] [Related]
9. Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release.
Ago Y; Tanaka T; Kita Y; Tokumoto H; Takuma K; Matsuda T
Neuropharmacology; 2012 Mar; 62(4):1634-9. PubMed ID: 22001792
[TBL] [Abstract][Full Text] [Related]
10. Behavioural and biochemical responses to methamphetamine are differentially regulated by mGlu2 and mGlu3 metabotropic glutamate receptors in male mice.
Busceti CL; Ginerete RP; Di Menna L; D'Errico G; Cisani F; Di Pietro P; Imbriglio T; Bruno V; Battaglia G; Fornai F; Monn JA; Pittaluga A; Nicoletti F
Neuropharmacology; 2021 Sep; 196():108692. PubMed ID: 34217776
[TBL] [Abstract][Full Text] [Related]
11. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
[TBL] [Abstract][Full Text] [Related]
12. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
[TBL] [Abstract][Full Text] [Related]
13. Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.
Procaccini C; Maksimovic M; Aitta-Aho T; Korpi ER; Linden AM
Neuroscience; 2013 Oct; 250():189-200. PubMed ID: 23867766
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
Fell MJ; Svensson KA; Johnson BG; Schoepp DD
J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
[TBL] [Abstract][Full Text] [Related]
15. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors.
Feenstra MG; Botterblom MH; van Uum JF
J Neurochem; 1998 Mar; 70(3):1104-13. PubMed ID: 9489731
[TBL] [Abstract][Full Text] [Related]
16. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
[TBL] [Abstract][Full Text] [Related]
17. Differentiating the roles of mGlu2 and mGlu3 receptors using LY541850, an mGlu2 agonist/mGlu3 antagonist.
Hanna L; Ceolin L; Lucas S; Monn J; Johnson B; Collingridge G; Bortolotto Z; Lodge D
Neuropharmacology; 2013 Mar; 66():114-21. PubMed ID: 22445601
[TBL] [Abstract][Full Text] [Related]
18. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.
Moghaddam B; Adams BW
Science; 1998 Aug; 281(5381):1349-52. PubMed ID: 9721099
[TBL] [Abstract][Full Text] [Related]
19. Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801.
Hámor PU; Šírová J; Páleníček T; Zaniewska M; Bubeníková-Valešová V; Schwendt M
Pharmacol Biochem Behav; 2018 Dec; 175():89-100. PubMed ID: 30240581
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of osemozotan, a serotonin 1A-receptor agonist, on methamphetamine-induced c-Fos expression in prefrontal cortical neurons.
Tsuchida R; Kubo M; Shintani N; Abe M; Köves K; Uetsuki K; Kuroda M; Hashimoto H; Baba A
Biol Pharm Bull; 2009 Apr; 32(4):728-31. PubMed ID: 19336914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
